Villeurbanne, Rhone-Alpes, France The venture was found in Europe in France. The main office of represented VC is situated in the Villeurbanne.
Besides them, we counted 2 critical employees of this fund in our database.
The fund has no specific favorite in a number of founders of portfolio startups. For fund there is a match between the location of its establishment and the land of its numerous investments - France. Among the most popular portfolio startups of the fund, we may highlight Tilkee, Skinjay, Olikrom. Among the most successful fund investment fields, there are Business Intelligence, CRM. Moreover, a startup needs to be at the age of 1 and less years to get the investment from the fund.
Speaking about the real fund results, this VC is 5 percentage points more often commits exit comparing to other organizations. The important activity for fund was in 2015. The common things for fund are deals in the range of 100 thousands - 1 million dollars. The fund is constantly included in less than 2 investment rounds annually. Opposing the other organizations, this Pertinence Invest works on 4 percentage points less the average amount of lead investments.
The typical case for the fund is to invest in rounds with 2-3 participants. Despite the Pertinence Invest, startups are often financed by Wilco. The meaningful sponsors for the fund in investment in the same round are KREAXI, Starquest Capital, Rhone-Alpes Creation. In the next rounds fund is usually obtained by KREAXI, Starquest Capital, Social Family Group.
Related Funds
| Fund Name | Location |
| 42CAP | Bayern, Germany, Munich |
| Arches Capital | Chicago, Illinois, United States |
| Arena Alpha | - |
| ARGO Group International | Delaware, Newark, United States |
| Carnegie | Stockholm, Stockholm County, Sweden |
| Givaudan | Geneva, Geneve, Switzerland |
| GLG Partners | England, London, United Kingdom |
| Huatsing Capital Management Co. Ltd. | Beijing, Beijing, China |
| Hunt Energy Enterprises | Dallas, Texas, United States |
| Mankekar Family Office | - |
| NES Partners | Copenhagen, Denmark, Hovedstaden |
| Qianhai Huaye Touzi | China, Japan, Kagoshima Prefecture |
| Qingying Fund | - |
| Scopely | California, Culver City, United States |
| Tenfore Holdings | New York, New York, United States |
| Texcel International | - |
| TOM Group Limited | China, Hong Kong, Hong Kong Island |
| Volvo Group Venture Capital | Gothenburg, Sweden, Vastra Gotaland |
| Xinjiang Dongfan | China, Ürümqi, Xinjiang |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Mablink Bioscience | $4M | 27 Apr 2021 | Lyon, Rhone-Alpes, France | ||
Skinjay | $849K | 03 Sep 2015 | France, Ile-de-France | ||
BIOMAE | $1M | 13 Mar 2015 | France, Auvergne-Rhône-Alpes, France | ||
Olikrom | $354K | 25 Feb 2015 | France, New Aquitaine | ||
AI4R | $118K | 01 Nov 2014 | Nantes, Pays de la Loire, France | ||
Tilkee | $590K | 12 Sep 2014 | Lyon, Auvergne-Rhône-Alpes, France | ||
Mathym | $708K | 30 Jun 2014 | France, Auvergne-Rhône-Alpes, France | ||
Argolight | $436K | 20 Nov 2013 | Pessac, Aquitaine, France | ||
Freemens SAS | 01 Jan 2013 | France, Auvergne-Rhône-Alpes, France |
– Mablink Bioscience is a Lyon, France-based company developing antibody-drug conjugates (ADC).
– The company raised €4M in a seed financing round.
– Elaia Partners led the round with participation from Pertinence Invest 2 (Sofimac Innovation advised by Mérieux Equity Partners), Sham Innovation Santé (advised by Turenne Capital), Fondation Fournier-Majoie, Simba Santé (Angelor) and Crédit Agricole Création.
– The new investment will be used to move forward its ADC pipeline.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Mablink Bioscience | $4M | 27 Apr 2021 | Lyon, Rhone-Alpes, France | ||
Skinjay | $849K | 03 Sep 2015 | France, Ile-de-France | ||
BIOMAE | $1M | 13 Mar 2015 | France, Auvergne-Rhône-Alpes, France | ||
Olikrom | $354K | 25 Feb 2015 | France, New Aquitaine | ||
AI4R | $118K | 01 Nov 2014 | Nantes, Pays de la Loire, France | ||
Tilkee | $590K | 12 Sep 2014 | Lyon, Auvergne-Rhône-Alpes, France | ||
Mathym | $708K | 30 Jun 2014 | France, Auvergne-Rhône-Alpes, France | ||
Argolight | $436K | 20 Nov 2013 | Pessac, Aquitaine, France | ||
Freemens SAS | 01 Jan 2013 | France, Auvergne-Rhône-Alpes, France |
